Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus

dc.contributor.author	Emral, R
dc.contributor.author	Haymana, C
dc.contributor.author	Demirci, I
dc.contributor.author	Tasci, I
dc.contributor.author	Sahin, M
dc.contributor.author	Cakal, E
dc.contributor.author	Ata, N
dc.contributor.author	Unluturk, U
dc.contributor.author	Demir, T
dc.contributor.author	Ertugrul, D
dc.contributor.author	Sahin, I
dc.contributor.author	Atmaca, A
dc.contributor.author	Celik, O
dc.contributor.author	Caglayan, M
dc.contributor.author	Arga, KY
dc.contributor.author	Dagdelen, S
dc.contributor.author	Salman, S
dc.contributor.author	Satman, I
dc.contributor.author	Sonmez, A
dc.date.accessioned	2022-10-05T13:18:58Z
dc.date.available	2022-10-05T13:18:58Z
dc.date.issued	2021
dc.identifier.uri	http://hdl.handle.net/11616/62685
dc.source	DIABETES THERAPY
dc.title	Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus
dc.title	Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish
dc.title	Nationwide Study (10.1007/s13300-021-01133-8, 2021)

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.